Neuropsychiatric events in varenicline and nicotine replacement patch users in the <scp>M</scp> ilitary <scp>H</scp> ealth <scp>S</scp> ystem

There does not appear to be an increase in neuropsychiatric hospitalizations with varenicline compared with nicotine replacement therapy patch over 30 or 60 days after drug initiation.